Agios Pharmaceuticals Inc Transmettre P/E
Quel est le Transmettre P/E de Agios Pharmaceuticals Inc?
Le Transmettre P/E de Agios Pharmaceuticals Inc est -3.82
Quelle est la définition de Transmettre P/E?
Le ratio prix à terme/bénéfice est le rapport entre le prix des actions d'une société et son bénéfice par action estimé pour les douze prochains mois.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Transmettre P/E des entreprises dans Health Care secteur sur NASDAQ par rapport à Agios Pharmaceuticals Inc
Que fait Agios Pharmaceuticals Inc?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Entreprises avec transmettre p/e similaire à Agios Pharmaceuticals Inc
- Peloton Interactive Inc a Transmettre P/E de -3.88
- aap Implantate AG a Transmettre P/E de -3.84
- Pharnext SA a Transmettre P/E de -3.84
- Tinka Resources a Transmettre P/E de -3.83
- Trilogy International Partners a Transmettre P/E de -3.82
- Midas Gold a Transmettre P/E de -3.82
- Agios Pharmaceuticals Inc a Transmettre P/E de -3.82
- Recon Technology Ltd a Transmettre P/E de -3.80
- Ballard Power Systems a Transmettre P/E de -3.79
- comScore a Transmettre P/E de -3.78
- Avenue Therapeutics Inc a Transmettre P/E de -3.74
- Compugen Ltd a Transmettre P/E de -3.73
- Vir Biotechnology Inc a Transmettre P/E de -3.70